SHARING IDEAS THAT DO GOOD

World-class, next-generation Influenza Vaccine Manufacturing Facility to be built in Aus

post-image
The world's second largest influenza vaccine provider will construct a new world-class biotech manufacturing facility in Australia - a $1.8 billion dollar deal in total. Seqirus who will invest $800 million, aims to supply influenza vaccines to Australia and across the globe with the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere. They will also manufacture their proprietary MF59 which is a substance added to some vaccines to improve immune response and reduce the amount of antigen in vaccines. This means that more doses can be manufactured quicker. | https://www.seqirus.com/news/seqirus-will-build-world-class-vaccine-manufacturing-facility
What do you think?

You must be logged in to post a comment.
Comments

Related Posts

Healthcare

https://youtu.be/jiwC4MHAL0E

 
17 May 2022 by Trevor Rowe 0 Comments

Healthcare

post-image

Know your healthcare rights
2 May 2022 by Trevor Rowe 0 Comments

Healthcare

post-image

Type 2 Diabetes is reversible
21 March 2022 by Trevor Rowe 0 Comments